Genomics England

Aug 8, 2024 | pressreleasepoint.com | Genomics England

Primary tabsView(active tab)Track Submitted by Genomics England on Thu, 08/08/2024 - 05:51 A pioneering study led by numerous UK universities and the Institute of Cancer Research, using data from the 100,000 Genomes Project, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer, also known as bowel cancer.

Apr 11, 2024 | onlinelibrary.wiley.com | Catherine N Jacott |Genomics England |Hicret Asli Yalcin |Ricardo Humberto Ramirez-Gonzalez

INTRODUCTION Necrosis- and ethylene-inducing like proteins (NLPs) are a superfamily of proteins widely found in bacteria, fungi and oomycetes (Seidl & Van den Ackerveken, 2019). NLPs can be present in microorganisms that are plant-pathogens but also occur in non-pathogenic taxa suggesting their role is not limited to virulence in plants (Bhatti et al., 2017; Tekaia & Latgé, 2005).

Apr 5, 2024 | academic.oup.com | Genomics England

Immunotherapy is an effective “precision medicine” treatment for several cancers. Imaging signatures of the underlying genome (radiogenomics) in glioblastoma patients may serve as pre-operative biomarkers of the tumor-host immune apparatus. Validated biomarkers would have the potential to stratify patients during immunotherapy clinical trials, and if trials are beneficial, facilitate personalized neo-adjuvant treatment.

Mar 20, 2024 | bmj.com | Richard Scott |Ellen Thomas |Interim CMO |Genomics England

Dear EditorRachel Horton and colleagues describe potential challenges related to the Generation Study[1]. The study will shortly launch and will examine the risks, benefits and broader implications of genomic newborn screening (gNBS), support new discovery through research and investigate storing an individual’s genome over their lifetime to support their healthcare.

May 9, 2023 | oncologyprofessionalcare.co.uk | Genomics England

Explore the latest advancements in genome sequencing and genomic testing, and the immediate and future potential for the development of precision medicine within the NHS and beyond. From discovery, research, development, and regulatory assessment, to delivery, supply and patient referral, you'll discover critical updates, gain practical learnings, and share insights with like-minded peers across patient care and science.